Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jianjia Robot has successfully developed the ARTHROBOT series of orthopedic surgical robots, with its hip and knee systems being the first domestic devices to receive Class III medical device registration certificates in China. The company also develops dental implant robotic systems. Clinical results indicate successful adoption and use in major hospitals, breaking the monopoly of imported joint replacement robots. Pipeline includes both late-stage and early-stage devices targeting orthopedic and dental indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jianjia Robot.